Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Pihusch

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
British Journal of Haematology|April 26, 2002
Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gutRudolf Pihusch, Christoph Salat, Peter Göhring, et al.
Anticancer Research|January 12, 2007
Extensive local and systemic therapy in extraneural metastasized glioblastoma multiformeSabrina T Astner, Rudolf Pihusch, Carsten Nieder, et al.
Transplantation|December 13, 2005
Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipientsMarkus Pihusch, Holger Wegner, Peter Goehring, et al.
Transplantation|October 8, 2005
Peripheral dendritic cell chimerism in allogeneic hematopoietic stem cell recipientsMarkus Pihusch, Stefan Boeck, Moritz Hamann, et al.
Molecular Oncology|December 4, 2024
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 studySusanne Klein-Scory, Alexander Baraniskin, Wolff Schmiegel, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF<sup>V600E</sup>-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)Lena Weiss, Sebastian Stintzing, Dominik Paul Modest, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2023
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) StudySebastian Stintzing, Kathrin Heinrich, David Tougeron, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Haematology|April 26, 2002
Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gutRudolf Pihusch, Christoph Salat, Peter Göhring, et al.
Anticancer Research|January 12, 2007
Extensive local and systemic therapy in extraneural metastasized glioblastoma multiformeSabrina T Astner, Rudolf Pihusch, Carsten Nieder, et al.
Transplantation|December 13, 2005
Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipientsMarkus Pihusch, Holger Wegner, Peter Goehring, et al.
Transplantation|October 8, 2005
Peripheral dendritic cell chimerism in allogeneic hematopoietic stem cell recipientsMarkus Pihusch, Stefan Boeck, Moritz Hamann, et al.
Molecular Oncology|December 4, 2024
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 studySusanne Klein-Scory, Alexander Baraniskin, Wolff Schmiegel, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF<sup>V600E</sup>-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)Lena Weiss, Sebastian Stintzing, Dominik Paul Modest, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2023
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) StudySebastian Stintzing, Kathrin Heinrich, David Tougeron, et al.
Pageof 2